Test Price
2,800 AEDโ Home Collection Available
BMP15 Gene Ovarian Dysgenesis Type 2 (OD2) Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
This diagnostic service provides 99.9% accurate next-generation sequencing of the BMP15 gene to confirm Ovarian Dysgenesis Type 2 (OD2), estimate familial recurrence risk, and guide fertility-preservation or hormone therapy decisions. Processing is conducted under ISO 9001:2015 accredited protocols.
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- โ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM โ 11 PM).
- โ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- โ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The BMP15 Gene Ovarian Dysgenesis Type 2 (OD2) test utilizes Next-Generation Sequencing (NGS) to analyze the coding regions and adjacent intronic boundaries of the BMP15 gene. Pathogenic variants in BMP15 are associated with premature ovarian insufficiency and ovarian dysgenesis. This high-resolution sequencing provides definitive molecular confirmation, enabling precise familial risk assessment and informed clinical management.
| Feature | DNA Labs UAE NGS | Alternative Sanger Sequencing |
|---|---|---|
| Coverage | Full gene (coding & adjacent intronic regions) | Targeted singleโexon focus |
| Sensitivity | 99.9% | ~95% in covered regions |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Bioinformatics | HGMD Pro + ACMG Classification | Manual variant calling |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics, I understand the profound implications a genetic diagnosis carries for both the patient and their family. The BMP15 result is one critical piece of a complex puzzle that must be integrated with hormonal profiles, pelvic imaging, and a detailed pedigree. Our team is dedicated to providing compassionate, precise interpretation to support you throughout your journey.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed hormone replacement therapy, fertility medications, or other therapies without consulting your personal physician. Test results guide, but do not replace, ongoing medical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Pregnancy (requires obstetric clearance); age under 18 years without mandatory parental consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Sample Safety: Prior allogeneic bone marrow transplant may interfere with germline DNA analysis; notify our clinical team.
- Emergency Red Flags: Sudden severe pelvic pain, heavy vaginal bleeding, or signs of ovarian torsion โ seek immediate emergency care, do not wait for test results.
- Genetic Counseling: Pre- and post-test genetic counseling is recommended and is integrated into our service protocol.
Patient FAQ & Clinical Guidance
1. What does the BMP15 gene ovarian dysgenesis type 2 test detect and why is it important?
The BMP15 gene test uses next-generation sequencing to identify pathogenic mutations that cause ovarian dysgenesis type 2, providing early clarity on ovarian reserve and familial risks. This information empowers your gynecologist to tailor fertility preservation strategies (e.g., oocyte cryopreservation) or hormone replacement timing, and enables accurate genetic counseling for female relatives who may carry the same variant.
2. How is the sample collected and what is the typical turnaround time?
A standard peripheral whole blood sample, a dried blood spot on an FTA card, or previously extracted DNA is collected via VIP Mobile Phlebotomy conducted at your home. The sample is transported using a Temperature-Controlled Cold-Chain logistics system to preserve DNA integrity. Results are delivered via a secure encrypted report within 3โ4 weeks, accompanied by an optional telephonic walk-through by our clinical genetics team.
3. Is this genetic test covered by insurance in the UAE, and how can I verify?
Most UAE-based insurance plans now cover clinically indicated genetic testing when referred by a DHA-licensed specialist. We handle direct billing verification for you. Simply send your insurance card and referral via WhatsApp to +971 54 548 8731 and our team confirms eligibility within 24 hours, scheduling your home collection at no upfront cost if approved.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with the UAEโs comprehensive legal framework for health data and genetic information:
- Data Security: Full adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for the collection, processing, and storage of your genetic and personal data.
- Health Information: Compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for secure digital health records and telemedicine guidance.
- Medical Liability & Consent: All clinical procedures and patient consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- DHA Licensing: Our facility operates under DHA Facility License Number 1143, located in Dubai Healthcare City, ensuring adherence to the highest standards of clinical governance.
Clinical & Logistical Metadata
| Test Name | BMP15 Gene Ovarian Dysgenesis Type 2 (OD2) NGS |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood / FTA Card / Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Q50.0 |
| LOINC Code | 21659-3 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians